Differential Interaction of Peripheral Blood Lymphocyte Counts (ALC) With Different in vivo Depletion Strategies in Predicting Outcomes of Allogeneic Transplant: An International 2 Center Experience

Dosing regimens for antithymocyte globulin (ATG) and anti-CD52 antibody (alemtuzumab) for graft vs. host disease prophylaxis (GVHD) are empiric or weight-based, and do not account for individual patient factors. Recently, it has been shown that recipient peripheral blood absolute lymphocyte count (A...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Oncol
Main Authors: Sheth, Vipul, Kennedy, Vanessa, de Lavallade, Hugues, Mclornan, Donal, Potter, Victoria, Engelhardt, Brian G., Savani, Bipin, Chinratanalab, Wichai, Goodman, Stacey, Greer, John, Kassim, Adetola, York, Sally, Kenyon, Michelle, Gandhi, Shreyans, Kulasekararaj, Austin, Marsh, Judith, Mufti, Ghulam, Pagliuca, Antonio, Jagasia, Madan, Raj, Kavita
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2019
Assuntos:
Oncology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6636242/
https://ncbi.nlm.nih.gov/pubmed/31355140
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2019.00623
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados